These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 4694352)

  • 1. The disposition kinetics of amphetamine in the ruminant animal.
    Baggot JD; Davis LE; Reuning RH
    Arch Int Pharmacodyn Ther; 1973 Mar; 202(1):17-27. PubMed ID: 4694352
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparative study of the pharmacokinetics of amphetamine.
    Baggot JD; Davis LE
    Res Vet Sci; 1973 Mar; 14(2):207-15. PubMed ID: 4805142
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of , -difluoro substitution on the disposition and pharmacological effects of 4-chloroamphetamine in rats.
    Fuller RW; Snoddy HD; Molloy BB
    J Pharmacol Exp Ther; 1973 Jan; 184(1):278-84. PubMed ID: 4686013
    [No Abstract]   [Full Text] [Related]  

  • 4. In vivo and in vitro inhibition of the metabolism of N-alkyl-substituted amphetamines in rat by ferrocenylisopropylamine.
    Vree TB; Henderson PT; von Rossum JM; Doukas PH
    Xenobiotica; 1973 Jan; 3(1):23-35. PubMed ID: 4701301
    [No Abstract]   [Full Text] [Related]  

  • 5. Certain aspects of amphetamine elimination in the horse.
    Baggot JD; Davis LE; Murdick PW; Ray RS; Noonan JS
    Am J Vet Res; 1972 Jun; 33(6):1161-4. PubMed ID: 5022396
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of amphetamine and its hydroxylated metabolites on central noradrenergic mechanisms.
    Taylor WA; Sulser F
    J Pharmacol Exp Ther; 1973 Jun; 185(3):620-32. PubMed ID: 4712653
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of chlorpromazine on the disposition and excretion of amphetamine in the rat.
    Borella LE; Pinski J; Herr F
    Res Commun Chem Pathol Pharmacol; 1970 Sep; 1(5):667-76. PubMed ID: 5524269
    [No Abstract]   [Full Text] [Related]  

  • 8. Relationships between pharmacokinetic and clinical parameters in chronic amphetamine abuse.
    Anggård E; Gunne LM; Jönsson LE
    Acta Pharmacol Toxicol (Copenh); 1970; 28(1):92. PubMed ID: 5314458
    [No Abstract]   [Full Text] [Related]  

  • 9. Amphetamine metabolism in amphetamine psychosis.
    Anggård E; Jönsson LE; Hogmark AL; Gunne LM
    Clin Pharmacol Ther; 1973; 14(5):870-80. PubMed ID: 4729903
    [No Abstract]   [Full Text] [Related]  

  • 10. Kinetics, salivary excretion of amphetamine isomers, and effect of urinary pH.
    Wan SH; Matin SB; Azarnoff DL
    Clin Pharmacol Ther; 1978 May; 23(5):585-90. PubMed ID: 25157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disposition kinetics of d- and l-amphetamine following intravenous administration of racemic amphetamine to rats.
    Hutchaleelaha A; Sukbuntherng J; Chow HH; Mayersohn M
    Drug Metab Dispos; 1994; 22(3):406-11. PubMed ID: 8070317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iprindole-amphetamine interactions in the rat: the role of aromatic hydroxylation of amphetamine in its mode of action.
    Freeman JJ; Sulser F
    J Pharmacol Exp Ther; 1972 Nov; 183(2):307-15. PubMed ID: 4673401
    [No Abstract]   [Full Text] [Related]  

  • 13. Disposition and behavioral effects of amphetamine and , -difluoroamphetamine in mice.
    Fuller RW; Molloy BB; Roush BW; Hauser KM
    Biochem Pharmacol; 1972 May; 21(9):1299-307. PubMed ID: 5038675
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the metabolism of sympathomimetic amines. The metabolism of ( )-( 14 C) amphetamine in the horse.
    Chapman DI; Marcroft J
    Xenobiotica; 1973 Jan; 3(1):49-61. PubMed ID: 4701302
    [No Abstract]   [Full Text] [Related]  

  • 15. Principles of drug distribution.
    Baggot JD
    Aust Vet J; 1974 Mar; 50(3):111-9. PubMed ID: 4604948
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro metabolism of sulfathiazole in rumen fluid and its metabolism and disposition kinetics following intraruminal administration in sheep.
    Jain SK; Hapke HJ
    Dtsch Tierarztl Wochenschr; 1995 May; 102(5):193-5. PubMed ID: 8593771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic interaction of psychotropic drugs. I. Divergent effect of mianserin on pharmacokinetics and pharmacodynamics of amphetamine.
    Chodera A; Cenajek D; Godlewski J
    Pol J Pharmacol Pharm; 1979; 31(6):609-13. PubMed ID: 575858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on sympathomimetic amines. II. The biotransformation and physiological disposition of d-amphetamine, d-p-hydroxyamphetamine and d-methamphetamine.
    AXELROD J
    J Pharmacol Exp Ther; 1954 Mar; 110(3):315-26. PubMed ID: 13143480
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on the CNS-availability of amphetamine from amphetaminil.
    Honecker H
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):121-8. PubMed ID: 1165132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spironolactone: disposition, metabolism, pharmacodynamics, and bioavailability.
    Karim A
    Drug Metab Rev; 1978; 8(1):151-88. PubMed ID: 363379
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.